title: Fluconazole-Induced Type 1 Kounis Syndrome.
abstract: The administration of fluconazole is commonly used in both inpatient and outpatient settings for the management of candidiasis infection. Although it is associated with a relatively safe side effect profile, some patients experience adverse effects associated with increased morbidity. We describe 1 such patient, a 42-year-old woman with a history of severe eczema who developed fluconazole-induced type 1 Kounis syndrome. Review of literature indicates that this as the first case reported of fluconazole-induced type 1 Kounis syndrome.
authors.affiliation: University of British Columbia, Vancouver, Canada.
authors.forename: Hardeep
authors.initials: H
authors.lastname: Singh Mahal
mesh_terms: D054058:Acute Coronary Syndrome / Q000139:chemically induced*; D000328:Adult; D000787:Angina Pectoris / Q000139:chemically induced*; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology; D004485:Eczema / Q000188:drug therapy; D005260:Female; D015725:Fluconazole / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D013577:Syndrome
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole